Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular assist device-induced reverse ventricular remodeling.

D Burkhoff1, J W Holmes, J Madigan

  • 1Department of Medicine, Columbia University, New York, NY 10032, USA. db59@columbia.edu

Progress in Cardiovascular Diseases
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate Effects of Transcatheter Aortic Valve Replacement on Left Ventricular Cardiac Mechanics in Moderate Aortic Stenosis: A Case Series With In Vivo Pressure-Volume Reconstructions.

Journal of cardiac failure·2025
Same author

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction.

ESC heart failure·2021
Same author

Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.

Clinical research in cardiology : official journal of the German Cardiac Society·2017
Same author

A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation.

Journal of molecular and cellular cardiology·2016
Same author

Early Activation of Metalloproteinases after Experimental Myocardial Infarction Occurs in Infarct and Non-infarct Zones.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

David operation: single center 10-year experience.

The Journal of cardiovascular surgery·2013
Same journal

Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies.

Progress in cardiovascular diseases·2026
Same journal

Multimodality imaging of vulnerable plaque: Are we there yet? A multifaceted perspective.

Progress in cardiovascular diseases·2026
Same journal

Beyond LDL-C: Triangulating residual risk via lipoprotein(a), remnant cholesterol, and vascular inflammation.

Progress in cardiovascular diseases·2026
Same journal

COVID-19 and coronary atherosclerosis: Unmasking and accelerating?

Progress in cardiovascular diseases·2026
Same journal

Mavacamten and left ventricular dysfunction in hypertrophic cardiomyopathy with left bundle branch block.

Progress in cardiovascular diseases·2026
Same journal

Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.

Progress in cardiovascular diseases·2026
See all related articles

Left ventricular assist devices (LVADs) can reverse heart failure by unloading the left ventricle. This leads to significant recovery of heart muscle structure and function, even in advanced cases.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Heart Failure Research

Background:

  • End-stage heart failure involves a dilated left ventricle.
  • Current treatments have limitations for advanced heart failure.

Purpose of the Study:

  • To evaluate the impact of left ventricular assist devices (LVADs) on myocardial remodeling and function.
  • To assess the potential for recovery in end-stage heart failure.

Main Methods:

  • Utilized left ventricular assist devices for chronic unloading of the left ventricle.
  • Assessed structural and molecular remodeling.
  • Evaluated myocardial contractility and response to stimuli.

Main Results:

  • LVADs induced reverse structural remodeling, normalizing the ventricle's pressure-volume relationship.

Related Experiment Videos

  • Observed reverse molecular remodeling, including increased expression of calcium metabolism genes.
  • Demonstrated improved baseline contractility and enhanced response to beta-agonist stimulation.

    • Conclusions:

    • LVADs facilitate significant recovery of myocardial properties in end-stage heart failure.
    • Previously irreversible myocardial damage may be reversible with LVAD support.
    • LVADs offer a promising therapeutic strategy for advanced heart failure patients.